A4M Peptide Therapy Certification 2026

Module II: Clinical Peptide Applications by Domain

🧬 Peptide Therapy Certification Module II

The A4M Peptide Therapy Certification 2026 – Module II: Clinical Peptide Applications by Domain
is the advanced second module of the Peptide Therapy Certification program, focused on the practical application of
peptide therapy across neurocognitive health, longevity, regenerative medicine, metabolic health, body composition, aesthetics, immune function, mitochondrial health, and healthy aging.

Module II moves into advanced clinical applications, combining
laboratory assessment, peptide bioregulators, neurotherapy, biological aging, cellular senescence, PRP, exosomes, GLP-1 therapies, skin and hair restoration, and emerging peptide and small-molecule therapies.

📦 Package Includes

🔬 Key Areas Covered

🧪 Compounds & Therapeutic Areas

The curriculum addresses numerous compounds and therapeutic areas, including

ARA-290, BPC-157, TB-500, Thymosin Alpha-1, CJC-1295, Ipamorelin, Sermorelin, MOTS-c, Semax, Selank, Humanin, SS-31, FOXO4-DRI, Epitalon, GHK-Cu, PT-141, Semaglutide, Tirzepatide, Retatrutide

and other peptide-related therapies.

📚 Module II Course Content

👨‍⚕️ Who Is This Course For?

Designed for licensed healthcare practitioners interested in advanced peptide therapy, longevity and anti-aging medicine, regenerative medicine, functional medicine, metabolic health, aesthetics, neurotherapy, and clinical optimization.